Skip to main content

Max Planck Institute to Use Waters Synapt HDMS to Study Protein Role in Brain Disease

NEW YORK (GenomeWeb News) - The Max Planck Institute of Biochemistry recently received one of Waters' mass spec systems, the Milford, Mass.-based company said Friday.
 
The Department of Cellular Biochemistry at the Martinsried, Germany-based institute will use the Synapt High Definition MS system to study the role of proteins in brain-wasting diseases such as Huntington's disease.
 
Manajit Hayer-Hartl, director and principal investigator for the department, said in a statement that the system will allow the researchers to characterize proteins of interest in great detail and said the ability to "separate species by ion mobility greatly enhances the appeal of this system."
 
Financial terms of the deal were not released.